loadpatents
name:-0.034882068634033
name:-0.017445087432861
name:-0.007206916809082
Baurin; Nicolas Patent Filings

Baurin; Nicolas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Baurin; Nicolas.The latest application filed is for "dual variable region antibody-like binding proteins having cross-over binding region orientation".

Company Profile
4.19.32
  • Baurin; Nicolas - Arpajon FR
  • Baurin; Nicolas - Paris FR
  • Baurin; Nicolas - Arpagjon FR
  • Baurin; Nicolas - St. Germain les Arpajon FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
App 20210189011 - Baurin; Nicolas ;   et al.
2021-06-24
Methods For Treating Inflammation Using Antibodies To Kallidin And Des-arg10-kallidin
App 20200115441 - Li; Han ;   et al.
2020-04-16
Antibodies to Plasminogen Activator Inhibitor-1 (PAI-1) and Uses Thereof
App 20190359729 - Pritsker; Alla ;   et al.
2019-11-28
Nucleic acids encoding antibodies to Kallidin and des-Arg.sub.10-Kallidin and host cells comprising the same
Grant 10,465,002 - Li , et al. No
2019-11-05
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide
App 20190119365 - Baurin; Nicolas ;   et al.
2019-04-25
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
Grant 10,112,991 - Baurin , et al. October 30, 2
2018-10-30
Methods For Treating Pain Using Antibodies To Kallidin And Des-arg10-kallidin
App 20180222967 - Li; Han ;   et al.
2018-08-09
Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
App 20180155450 - Baurin; Nicolas ;   et al.
2018-06-07
Antibodies to Plasminogen Activator Inhibitor-1 (PAI-1) and Uses Thereof
App 20180155444 - Pritsker; Alla ;   et al.
2018-06-07
Methods for treating pain using antibodies to Kallidin and des-Arg.sub.10-Kallidin
Grant 9,879,079 - Li , et al. January 30, 2
2018-01-30
Antibodies to plasminogen activator inhibitor-1 (PAI-1) and uses thereof
Grant 9,845,363 - Pritsker , et al. December 19, 2
2017-12-19
Antibodies To Kallidin And Des-arg9-kallidin
App 20160368976 - Li; Han ;   et al.
2016-12-22
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide
App 20160368977 - Baurin; Nicolas ;   et al.
2016-12-22
Antagonist antibodies and their fab fragments against GPVI and uses thereof
Grant 9,441,040 - Baurin , et al. September 13, 2
2016-09-13
Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
App 20160200811 - Baurin; Nicolas ;   et al.
2016-07-14
Antibodies to Plasminogen Activator Inhibitor-1 (PAI-1) and Uses Thereof
App 20160200831 - Pritsker; Alla ;   et al.
2016-07-14
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
Grant 9,382,312 - Baurin , et al. July 5, 2
2016-07-05
Antibodies to kallidin and des-Arg.sub.9-kallidin
Grant 9,376,494 - Li , et al. June 28, 2
2016-06-28
Peptide Or Peptide Complex Binding To Alpha2 Integrin And Methods And Uses Involving The Same
App 20160176970 - Corvey; Carsten ;   et al.
2016-06-23
Peptide or peptide complex binding to ALPHA2 integrin and methods and uses involving the same
Grant 9,234,039 - Corvey , et al. January 12, 2
2016-01-12
Dual variable region antibody-like binding proteins having cross-over binding region orientation
Grant 9,221,917 - Baurin , et al. December 29, 2
2015-12-29
Dual variable region antibody-like binding proteins having cross-over binding region orientation
Grant 9,181,349 - Baurin , et al. November 10, 2
2015-11-10
Macrolide Derivatives, Preparation Thereof And Therapeutic Use Thereof
App 20150210729 - BAURIN; Nicolas ;   et al.
2015-07-30
Novel Antagonist Antibodies And Their Fab Fragments Against Gpvi And Uses Thereof
App 20150098939 - BAURIN; Nicolas ;   et al.
2015-04-09
Antibodies To Bradykinin B1 Receptor Ligands
App 20150050270 - Li; Han ;   et al.
2015-02-19
In Silico Affinity Maturation
App 20140335102 - Oberlin; Michael ;   et al.
2014-11-13
Antagonist antibodies and their fab fragments against GPVI and uses thereof
Grant 8,852,593 - Baurin , et al. October 7, 2
2014-10-07
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide
App 20140105890 - BAURIN; Nicolas ;   et al.
2014-04-17
Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
App 20140056895 - Baurin; Nicolas ;   et al.
2014-02-27
Humanized anti-CXCR5 antibodies, derivatives thereof and their use
Grant 8,647,622 - Lee , et al. February 11, 2
2014-02-11
Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
App 20140011238 - Baurin; Nicolas ;   et al.
2014-01-09
Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
App 20130345404 - Baurin; Nicolas ;   et al.
2013-12-26
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
Grant 8,614,299 - Baurin , et al. December 24, 2
2013-12-24
Peptide Or Peptide Complex Binding To 2 Integrin And Methods And Uses Involving The Same
App 20130156786 - Corvey; Carsten ;   et al.
2013-06-20
Anti-gitr Antibodies
App 20130108641 - Baurin; Nicolas ;   et al.
2013-05-02
Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
App 20120251541 - Baurin; Nicolas ;   et al.
2012-10-04
Novel Antagonist Antibodies And Their Fab Fragments Against Gpvi And Uses Thereof
App 20120244152 - Baurin; Nicolas ;   et al.
2012-09-27
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide
App 20120177639 - Baurin; Nicolas ;   et al.
2012-07-12
Fgf-r4 Receptor-specific Antagonists
App 20110150903 - Baurin; Nicolas ;   et al.
2011-06-23
Humanized anti-CXCR5 antibodies, derivatives thereof and their use
App 20110027266 - Lee; Renata ;   et al.
2011-02-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed